The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Poole Jonathan since 2016.
This trader's CIK number is 1604689.
At the time of last reporting, Poole Jonathan was the Officer of Acadia Pharmaceuticals Inc. (stock ticker symbol ACAD).
Also see all insider trading activities at Acadia Pharmaceuticals Inc.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | GNCA | 0 | $0 | 51,213 | $310,446 | 45,000 | $139,050 |
| 2016 | GNCA | 11,000 | $38,900 | 0 | $0 | 0 | $0 |
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | ACAD | 0 | $0 | 0 | $0 | 2,010 | $0 |
1. Genocea Biosciences, Inc. (GNCA)
2. Acadia Pharmaceuticals Inc (ACAD)
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-07-24 | GNCA | Sale | 45,000 | 6.00 | 270,000 |
| 2017-07-24 | GNCA | Option Ex | 45,000 | 3.09 | 139,050 |
| 2017-05-08 | GNCA | Sale | 6,213 | 6.51 | 40,446 |
| 2016-11-07 | GNCA | Buy | 7,000 | 3.34 | 23,380 |
| 2016-05-09 | GNCA | Buy | 4,000 | 3.88 | 15,520 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-05-29 | ACAD | Option Ex | 2,010 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Poole Jonathan (Officer of Acadia Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.